NCT04618081 2025-07-08Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)CelgeneCompleted151 enrolled
NCT06250595 2024-02-09ENROLHospital Universitari Vall d'Hebron Research InstituteRecruiting37,090 enrolled
NCT00315419 2010-04-21Identifying Characteristics of Bone Marrow Failure SyndromesOffice of Rare Diseases (ORD)Unknown450 enrolled